Sold by: Next Move Strategy Consulting
Expert-led strategic advisory on RSV diagnostics and MedTech data architecture. Includes a live analyst briefing evaluating the shift to multiplex panels and scaling secure diagnostic data on Amazon Web Services (AWS).
Overview
Engagement Overview
This Professional Service engagement provides your organization with a deep-dive strategic assessment of the Global Respiratory Syncytial Virus (RSV) Diagnostic Testing ecosystem. As the healthcare sector shifts toward multiplexing and highly accurate point-of-care (POC) solutions, organizations must manage increasingly complex clinical data. Our industry experts guide your leadership team through the technical nuances of the market—specifically the move from traditional rapid antigen tests to molecular (PCR) platforms—and how to align these MedTech advancements with modern IT infrastructure.
AWS Architecture & Implementation Strategy
A critical component of modernizing MedTech is building secure, HIPAA-compliant cloud architectures. We guide healthcare leaders on operationalizing diagnostic market trends using Amazon Web Services (AWS). Our insights help clients strategize the secure management of multiplex testing data using AWS HealthLake, connect point-of-care (POC) medical devices via AWS IoT Core, and scale clinical laboratory data securely on AWS cloud infrastructure.
What You Receive
Live Analyst Strategy Session (60 Minutes): Consult directly with a lead MedTech analyst to deconstruct the "Gold Standard" shift. This private session is tailored to your specific R&D hurdles and healthcare IT integration challenges.
Complete Market Data Repository: Gain full access to our underlying research architecture on the Global RSV Diagnostic Testing Market (2026-2035). Includes granular CAGR data, regional adoption shifts, and performance benchmarking for point-of-care vs. laboratory segments.
Executive Action Brief: A custom analysis of the diagnostic ecosystem translating complex clinical trends—like the demand for under-20-minute PCR accuracy—into actionable IT and R&D roadmaps for scaling on AWS.
Who Should Engage
- Chief Technology Officers (CTOs) and VPs of R&D in MedTech
- Healthcare IT & Clinical Data Transformation Leaders
- Venture Capital & Private Equity Partners assessing diagnostic targets
Highlights
- Consult directly with a lead analyst to deconstruct the shift to multiplex PCR platforms and contextualize it for your digital healthcare strategy.
- Gain full access to granular CAGR data, regional adoption shifts, and performance benchmarking for POC vs. laboratory diagnostic segments.
- Actionable intelligence for MedTech leaders, including guidance on securing clinical data using AWS HealthLake and connecting diagnostic devices via AWS IoT Core.
Details
Categories
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Pricing
Custom pricing options
Pricing is based on your specific requirements and eligibility. To get a custom quote for your needs, request a private offer.
Legal
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Resources
Support
Vendor support
Support Availability: Our analyst team is available Mon-Fri, 9:00 AM - 6:00 PM EST for scheduling briefings and answering follow-up questions.
Contact Process: Upon purchase, please email us at info@nextmsc.com with your order ID to schedule your 60-minute analyst briefing. We typically respond to all scheduling requests within 24 hours.